Abstract
This study explored the efficacy of 1 actigraphy (ACT) brand, at different analytic settings, for use to administer the Multiple Sleep Latency Test (MSLT). Forty-one first-time postpartum mother and father participants were administered the MSLT with concurrent ACT. To identify ACT sleep onset latency (SOL), ACT signals were interpreted with iterations of different “wake threshold value” (WTV) and “immobile minutes for sleep onset” value (IMV) settings. The different iterations of ACT–SOL values were compared to MSLT–SOL values. The WTV settings did not affect ACT–SOL, but the ACT–SOL and MSLT–SOL significantly differed at each ACT–IMV setting. ACT consistently identified SOL too soon; however, future research, along with technological innovation, may identify a viable methodology to conduct an ambulatory MSLT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.